PATIENT-CONTROLLED ANALGESIA FOR SICKLE-CELL-RELATED PAIN

被引：41

作者：

SHAPIRO, BS

COHEN, DE

HOWE, CJ

机构：

[1] Division of General Pediatrics, Children's Hospital of Philadelphia

[2] Department of Anesthesiology, Children's Hospital of Philadelphia

[3] Department of Nursing, Children's Hospital of Philadelphia

[4] The University of Pennsylvania School of Medicine, Philadelphia, PA

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1993年 / 8卷 / 01期

关键词：

SICKLE-CELL DISEASE; PAIN; CRISIS PAIN; VASOOCCLUSION; PATIENT-CONTROLLED ANALGESIA; OPIOIDS; ANALGESIA; PATIENT PREFERENCE; CHRONIC ILLNESS;

D O I：

10.1016/0885-3924(93)90116-D

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

To delineate dose ranges, utilization patterns, and the frequency and types of problems encountered, we retrospectively reviewed the medical records of 46 patients with sickle hemoglobinopathies who used patient-controlled analgesia (PCA) a total of 92 times for the management of vasoocclusive pain. Patients varied widely in the drug administered, use of basal infusion, individual dose, and total amount of drug received. On the day of heaviest use, the average maximum hourly dose was equivalent to 0. 09 mg/kg of morphine. In this study, 11 patients and two families disliked PCA, one patient had respiratory compromise, and one patient tampered with the machine. Patient satisfaction with PCA probably reflects interactions among the psychosocial impact of chronic illness and chronic pain, individual psychological and temperamental factors, environmental contingencies, and the expectations and beliefs of the family and the health-care professionals. Based on this experience, recommendations can be proposed for the use of PCA in this condition.

引用

页码：22 / 28

页数：7

共 26 条

[1]

Brozovic, Davies, Brownell, Acute admissions of patients with sickle cell disease who live in Britain, BMJ, 294, pp. 1206-1208, (1987)

[2]

Tetrault, Scott, Five year retrospective study on hospitalization and treatment of sickle cell anemia patients, Proceedings of the First National Symposium on Sickle Cell Disease, (1974)

[3]

Schechter, Berrien, Katz, The use of patient-controlled analgesia in adolescents with sickle cell pain crisis: a preliminary report, J Pain Symptom Manage, 3, pp. 109-113, (1988)

[4]

Batenhorst, Maurer, Bertch, Et al., Patient controlled analgesia in uncomplicated sickle cell pain crisis, Blood, 70, (1987)

[5]

Holbrook, Patient-controlled analgesia pain management for children with sickle cell disease, J Assoc Acad Minority Phys, 1, pp. 93-96, (1990)

[6]

Gonzalez, Bahal, Hansen, Et al., Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain, Arch Intern Med, 151, pp. 1373-1378, (1991)

[7]

Benedetti, Butler, Systemic analgesics, The management of pain, (1990)

[8]

Rucknagel, Kalinyak, Gelfand, Rib infarcts and acute chest syndrome in sickle cell diseases, Lancet, 337, pp. 831-833, (1991)

[9]

Sprinkle, Cole, Smith, Et al., Acute chest syndrome in pediatric patients with sickle cell disease: a retrospective analysis of 100 hospitalized patients, Am J Pediatr Hematol Oncol, 8, pp. 105-110, (1986)

[10]

Haynes, Allison, Pulmonary edema: complication in the management of sickle cell pain crisis, Am J Med, 80, pp. 833-840, (1986)

← 1 2 3 →